Lokich J J
Cancer Center, Boston.
Postgrad Med. 1990 Feb 1;87(2):239-41, 244-6. doi: 10.1080/00325481.1990.11704570.
Chemotherapy delivered by infusion has developed in the last decade, primarily as a consequence of advances in technology but perhaps also because of increasing scientific understanding of pharmacology and tumor cell kinetics. Although few prospective, randomized trials have compared infusion-delivery with bolus-delivery schedules, those that have been performed have found that the infusion schedule provides at least a comparable response rate while improving drug toxicity.
过去十年间,通过静脉输注给药的化疗方法得到了发展,这主要得益于技术的进步,但也可能是由于对药理学和肿瘤细胞动力学的科学认识不断加深。尽管很少有前瞻性随机试验比较过静脉输注给药方案和大剂量推注给药方案,但已进行的那些试验发现,静脉输注给药方案在提高药物毒性的同时至少能提供相当的缓解率。